OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Human Papilloma Virus Vaccines (HPV)

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Human Papilloma Virus Vaccines (HPV)"

Transcription

1 OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Human Papilloma Virus Vaccines (HPV) Revisions as of Vaccination age changed to clients 7 years of age Removal of adolescent well visit flyer I. OREGON IMMUNIZATION PHARMACY PROTOCOL: 1. Check the ALERT Immunization Information System (IIS) to determine whether the patient needs this vaccine and any other vaccines. 2. Screen clients 7 years for contraindications. 3. Provide a current Vaccine Information Sheet (VIS) answering any questions. 4. Record all required data elements in the client s permanent health record. 5. Give HPV vaccine 0.5 ml intramuscularly (deltoid preferred) as appropriate for the age and sex of the patient. 6. Simultaneous vaccination may be given with all routine adolescent or adult vaccines. 7. Observe client for 15 minutes after vaccination to decrease the risk for injury should they faint. Immunizing Pharmacist Signature Date For multiple signatures see:

2 II. LICENSED HUMAN PAPILLOMAVIRUS (HPV) VACCINE H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 2 of 14 Product Name Vaccine Components Acceptable Age Range Recommended Age Thimerosal Gardasil 9 * (HPV 9) Gardasil * (HPV 4) Protein of HPV types 6, 11, 16, 18, 31, 33, 45, 52, 58 Protein of HPV types 6, 11, 16, and 18 Female 9 26 ** years yrs Male 9 26 years ** yrs Female 9 26 years ** yrs Male 9 26 years ** yrs None None Cervarix (HPV 2) Protein of HPV types 16 and 18 Female only 9 26 ** yrs None * HPV 4 is designed to prevent HPV 6 & 11 type genital warts and HPV 16, 18. HPV 9 is designed to prevent an additional five strains: 31, 33, 45, 52, and 58 which are related to cervical cancer, cervical dysplasias, vulvar or vaginal dysplasias, and anal cancers. 1 ACIP recommends routine HPV vaccination for all males 9 21 years and for some males years of age. See section III.4 recommendations for special populations. 1 HPV vaccine can be given simultaneously with all scheduled vaccines. 8 Designed to prevent HPV 16 and 18 related to cervical cancers, cervical intraepithelial neoplasia grade 2 or worse and adenocarcinoma in situ and cervical intraepithelial neoplasia grade 1. 5 ** If persons reach age 27 years before the HPV vaccination series is complete, the second and or third doses of vaccine can be administered. 2

3 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 3 of 14 III. RECOMMENDATIONS FOR USE 1. Routine vaccination of females and males years of age with 3 doses of sexappropriate HPV vaccine. The vaccine series can begin at age 9 years.* 2. HPV vaccination is also routinely recommended for females years of age not previously vaccinated or who have not completed the full HPV series.* a. Vaccinate with HPV2, HPV4, or HPV9 for prevention of cervical cancers and precancerous lesions. b. Vaccinate with the HPV4 or HPV9 vaccine for prevention of cervical cancer, cervical dysplasias, vulvar or vaginal dysplasias, and anal cancers. ** 3. HPV4 and HPV9 vaccination is routinely recommended for males years of age not previously vaccinated or who have not completed the full HPV series. ** 4. Immunosuppressed males and men who have sex with men (MSM) years of age should be vaccinated. Other males years of age may be vaccinated at their request. ** 5. If persons reach age 27 years before the HPV vaccination series is complete, the second and or third doses of vaccine can be administered. * *HPV vaccines are not recommended for use in pregnancy. If a woman is found to be pregnant after initiation of HPV vaccination series, the remainder of the 3 dose series should be delayed until completion of the pregnancy. 1 Persons who are immunocompromised either from disease or medication can receive HPV4 vaccine. However, the immune response and vaccine effectiveness might be less than in those who are immunocompetent. 2 ACIP states that the HPV series doses 2 and 3 may be completed if the series was started at 26 years of age. 2 HPV4 is indicated for use against vulvar and vaginal cancers and pre-cancers. 3 ** HPV4 has also been demonstrated to protect against anal cancers and anal intraepithelial neoplasias. 3

4 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 4 of 14 IV. RECOMMENDED BLENDED VACCINE SCHEDULE FOR Gardasil 4 or 9 * ** and Cervarix (HPV2) ** Dose and Route: 0.5mL IM Dose Recommended Age Minimum Age years *** 9 years 2 Recommended Spacing 1 2 months after 1 st dose 3 6 months after 1 st dose Minimum Spacing 4 weeks after 1 st dose 12 weeks after 2 nd dose and 24 weeks after 1 st dose * If vaccine history or specific HPV product is unknown, any available HPV vaccine product may be used to continue or complete the series for females for protection against HPV 16 and HPV4 or HPV9 may be used to continue or complete the series for males. 1 There are no data on efficacy of fewer than 3 doses of HPV9. 1 Cervarix is approved for use in females only. ** Approved for use in persons 9 26 years of age. 2 Ideally, vaccine should be administered before potential exposure to HPV through sexual contact. 2 Any HPV series with <3 doses of HPV might provide less protection than a complete 3-dose series of HPV. 2 Approved for use in females 9 26 years of age and for males 9 21 years, and for some males years of age. See section III.4. 1, 2 *** ACIP recommended age for vaccination is years of age. Providers should take advantage of any opportunity to vaccinate persons as young as 9 years of age. 2 For retrospective evaluation only, the third (3) dose can be considered to be valid if it was separated from the first (1) dose by at least 16 weeks and from the second (2) dose by at least 12 weeks. 2

5 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 5 of 14 Note: If the vaccination schedule is interrupted, the vaccine series does not need to be restarted. 1, 2 V. CONTRAINDICATIONS: For persons with a history of immediate hypersensitivity to any vaccine component 1 For GARDASIL ; a history of immediate hypersensitivity to yeast 1 For CERVARIX ; do not use prefilled syringes for individuals who have had anaphylactic reactions to latex 1 Pregnancy 1 : HPV vaccines are not to be given during pregnancy. Pregnancy registries for HPV4 and HPV2 have been closed. A new pregnancy registry has been established for HPV9. Exposure during pregnancy can be reported to the respective manufacturer: o HPV9 report to Merck Pregnancy Registry at o HPV4 report to Merck at o HPV2 to GlaxoSmithKlein at All clinics and pharmacies enrolled with the VFC program must report exposure during pregnancy to VAERS (see section X). VI. PRECAUTIONS: HPV vaccine can be administered to persons with minor acute illnesses (e.g.,) diarrhea or mild upper respiratory tract infections, with or without fever). 2 Vaccination of people with moderate or severe acute illnesses should be deferred until after the illness improves. 2 Observe client for 15 minutes in case of syncope. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following HPV vaccination. When syncope is associated with tonic-clonic movements, the activity is usually transient and typically responds to restoring cerebral perfusion by maintaining a supine or Trendelenburg position. 2

6 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 6 of 14 VII. SIDE EFFECTS AND ADVERSE REACTIONS Table 1: Injection site and systemic adverse reactions occurring within five days of each vaccination with Gardasil 9 and Gardasil 4 in girls and women. Gardasil 9 Gardasil 4 After any dose After any dose Number followed for Safety N=7071 N=7078 % % Age in Years Injection Site Adverse Reactions Pain (any) Redness (any) Swelling (any) Systemic Adverse Reactions N=7022 N=7024 Temperature > Temperature > Age in Years 9 15 N =299 N=300 Injection Site Adverse Reactions Pain (any) Redness (any) Swelling (any) Systemic Adverse Reactions N=299 N=300 Temperature > Temperature > Gardasil 9 package insert table 1 page 5 3

7 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 7 of 14 Table 2: Rates (%) of solicited and unsolicited injection-site and systemic adverse reactions among boys 9 through 15 years of age who received Gardasil 9 Gardasil 9 Study Number: NCT Number followed for Safety N =639 Adverse Reaction % Age in Years: 9 through 15 Solicited Local Reaction, Injection site 1 5 days post-vaccination, any dose Pain 71.5 Redness 24.9 Swelling 26.9 Solicited Systemic Adverse Reaction Oral Temp F (n= 637) 10.4 Unsolicited Local Reaction, Injection site 1 5 days post-vaccination, any dose Injection-Site Hematoma 1.3 Injection-Site Induration 1.1 Unsolicited Systemic Adverse Reactions 1 15 days post-vaccination, any dose Headache 9.4 Pyrexia * 8.9 Nausea 1.3 * Report of feeling febrile Gardasil 9 package insert table 3 page 6 3

8 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 8 of 14 Table 3: GARDASIL 4 : Adverse reactions in males and females 9 26 years of age 1 5 days post vaccination. 4 Gardasil AAHS Control * Saline Placebo Number followed for Safety N =5088 N=3470 N=320 % % % Age in Years 9 26 Females Local Reaction, Injection site 1 5 days post-vaccination Pain Redness Swelling Itching Bruising Systemic Reaction 1 5 days post-vaccination Pyrexia ** Headache Number followed for Safety N=3093 N=2029 N=274 Age in Years 9 26 Males Local Reaction, Injection site 1 5 days post-vaccination Pain Redness Swelling Hematoma Systemic Reaction 1 5 days post-vaccination Pyrexia ** Headache * AHHS Control: Amorphous Aluminum Hydroxyphosphate Sulfate Gardasil 4 package insert table 1 page 4 4 Gardasil 4 package insert table 2 page 4 4 Gardasil 4 package insert table 5 page 6 4 ** Report of feeling febrile

9 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 9 of 14 Post-dose evaluation of fever in girls and women 9 26 years of age (1 5 days postvaccination) Temperature (F ) After dose 1 N=4945 Gardasil 4 % occurrence After dose 2 N=4804 After dose 3 N=4671 AHHS Control * or Saline Placebo % occurrence After dose 1 N=3681 After dose 2 N = 3564 After dose 3 N= to < Gardasil 4 package insert page 7 4 * AHHS Control: Amorphous Aluminum Hydroxyphosphate Sulfate: adjuvant Post-dose evaluation of fever in boys and men 9 26 years of age (1 5 days postvaccination) Temperature (F ) After dose 1 N=2972 Gardasil 4 % occurrence After dose 2 N=2849 After dose 3 N=2792 AHHS Control * or Saline Placebo % occurrence After dose 1 N=2194 After dose 2 N = 2079 After dose 3 N= to < Gardasil 4 package insert page 7 4 * AHHS Control: Amorphous Aluminum Hydroxyphosphate Sulfate

10 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 10 of 14 VII. SIDE EFFECTS AND ADVERSE REACTIONS Cont. Table 4: CERVARIX : Adverse reactions in females 9 25 years of age 7 days postvaccination.* 5 Cervarix AI(0H) 3 Control Number followed for N=6669 N=549 Safety % % Age in Years Local Reaction, Injection site Pain Redness Swelling Systemic Reaction N=6670 N=549 Rash Fever (<99.5 F) Headache Tiredness Gastro-intestinal N=6119 Joint Pain 20.7 Muscle pain 48.8 Hives 7.2 *Package insert table 1 page 5. 5 Al(OH) 3 Control: Aluminum hydroxide, 500 mcg. 5 A general term for any eruption that appears on the skin. Not permanent. 8 Multiple swollen raised areas on the skin that are migratory, intensely itchy, and last up to 24 hours. 8

11 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 11 of 14 VIII. OTHER CONSIDERATIONS A. Cervical cancer screening is recommended beginning at age 21 years and continuing through age 65 years for both vaccinated and unvaccinated women. 1 B. Pap test: HPV screenings are approved for use with Papanicolaou (Pap) test for routine screening in women >30 years of age or for following up certain abnormal Pap test results. One HPV screening has been approved for primary cervical cancer screening but is not currently part of national recommendations. There are no other approved indications for clinical HPV testing. Screening is not necessary prior to receiving HPV vaccine. 2 C. Abnormal Pap test: This vaccine can be given to females who have an equivocal or abnormal Pap test, a positive Hybrid Capture II high-risk test, or genital warts. However, vaccine recipients should be advised that the vaccine will not have any therapeutic effect on existing Pap test abnormalities, HPV infection or genital warts. Vaccination of these females would provide protection against infection with vaccine HPV types not already acquired. 2 D. Lactating women can receive HPV vaccine. 2 E. HPV vaccine is recommended through age 26 years for men who have sex with men and for immunocompromised persons (including those who have had transplants or HIV infection), who have not been vaccinated previously or have not completed the 3 dose series. These individuals are more likely to develop HPV-associated disease and cancer. 1,2 F. It is unclear whether there will be any difference in response to vaccination between immunocompromised and immunocompetent persons. 2 G. There are no data on efficacy of fewer than 3 doses of HPV vaccine. 1

12 3, 4, 5 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 12 of 14 IX. STORAGE AND HANDLING All clinics and pharmacies enrolled with the VFC program must immediately report any storage and handling deviations to their health educator. A map of the Health Educator assignments is available at: GARDASIL 9 is supplied in vials and syringes: Store refrigerated at 2 to 8 C (36 to 46 F). Do not freeze Protect from light GARDASIL9 should be administered as soon as possible after being removed from refrigeration GARDASIL 9 can be administered provided total (cumulative multiple excursion) time out of refrigeration (at temperatures between 8 C and 25 C) does not exceed 72 hours. Cumulative multiple excursions between 0 C and 2 C are also permitted as long as the total time between 0 C and 2 C does not exceed 72 hours. These are not, however, recommendations for storage. GARDASIL is supplied in vials and syringes: Store refrigerated at 2 to 8 C (36 to 46 F). Do not freeze Protect from light GARDASIL should be administered as soon as possible after being removed from refrigeration GARDASIL can be out of refrigeration at temperatures at or below 25 C/77 F for a total time of not more than 72 hours CERVARIX is available in 0.5-mL single-dose disposable prefilled TIP-LOK syringes (packaged without needles): Store refrigerated between 2º and 8ºC (36º and 46ºF) Do not freeze Discard if the vaccine has been frozen Upon storage, a fine, white deposit with a clear, colorless supernatant may be observed. This does not constitute a sign of deterioration

13 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 13 of 14 X. ADVERSE EVENTS REPORTING Adverse events following immunization must be reported to the Vaccine Adverse Events Reporting System (VAERS). The VAERS online report form is available at A pharmacist who administers any vaccine must report the following elements to the OHA ALERT Immunization Information System in a manner prescribed by OHA within 15 days of administration. This replaces the former requirement to notify the primary health care provider. A pharmacist is not required to notify the primary health care provider. Oregon Administrative Rule (2). 9 To request this material in an alternative format (e.g., Braille) or to clarify any part of the above order, contact the Oregon Health Authority Immunization Program at and 711 for TTY. For other questions, consult with the vaccine recipient s primary health care provider or a consulting physician. Electronic copy of this protocol available at: 1.usa.gov/PharmacyImmunizationProtocols

14 H u m a n P a p i l l o m a V i r u s V a c c i n e P a g e 14 of 14 REFERENCES 1. CDC. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR 2015; 64; Available at: Accessed 27 March CDC. Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR 2014; 63(RR05); Available at: Accessed 31 March Gardasil 9 package insert (p5). Available at: pdf. Accessed 31 March Gardasil package insert. Available at: pdf. Accessed 31 March Cervarix package insert. Available at: pdf. Accessed 31 March Human Papillomavirus. In: Epidemiology and Prevention of Vaccine-Preventable Diseases ( Pink Book ). Atkinson W, Hamborsky J, Wolfe S, eds. 12 th ed. Washington, DC: Public health foundation, May, Available at: Accessed 18 December CDC. General Recommendations on Immunizations. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011; 60 (RR-2). Available at: 8. Merck Manual. Available at: he_dermatologic_patient/urticaria.html Accessed 15 December Oregon Administrative Rule. Board of Pharmacy. Division 19. Licensing of pharmacists: (2). Available at: Accessed 12 May 2015.

OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMICSTS HUMAN PAPILLOMAVIRUS (HPV) VACCINE QUADRAVALENT AND BIVALENT

OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMICSTS HUMAN PAPILLOMAVIRUS (HPV) VACCINE QUADRAVALENT AND BIVALENT OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMICSTS HUMAN PAPILLOMAVIRUS (HPV) VACCINE QUADRAVALENT AND BIVALENT Revisions on 2/23/2010 are based on recent Advisory Committee on Immunization Practices

More information

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by Immunization Healthcare Branch Human Papillomavirus Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 02 Jan 14 www.vaccines.mil

More information

OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS. PNEUMOCOCCAL POLYSACCHARIDE, PPSV23 and CONJUGATE VACCINE, PCV13

OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS. PNEUMOCOCCAL POLYSACCHARIDE, PPSV23 and CONJUGATE VACCINE, PCV13 Revision September 2010 OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS PNEUMOCOCCAL POLYSACCHARIDE, PPSV23 and CONJUGATE VACCINE, PCV13 Addition of Prevnar 13 (PCV13) which replaces Prevnar

More information

Brought to you by. [ your information / logo here ]

Brought to you by. [ your information / logo here ] Brought to you by [ your information / logo here ] 1 1 2 2 3 3 HPV can infect anyone Human papillomavirus (HPV) is a widespread virus that can infect most males and females in their lifetime. For most,

More information

Brought to you by [ your information / logo here ]

Brought to you by [ your information / logo here ] Brought to you by [ your information / logo here ] 1 1 2 2 3 3 HPV can infect anyone Human papillomavirus (HPV) is a widespread virus that can infect most males and females in their lifetime. For most,

More information

One infected partner may be all it takes to get HPV.

One infected partner may be all it takes to get HPV. One infected partner may be all it takes to get HPV. HPV can cause cervical cancer in females and genital warts in males and females. Look inside to find out more. HPV=human papillomavirus HPV: What you

More information

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 1 Background l Selected types of HPV cause cervical cancer, anogenital warts, and other anogenital and

More information

Supplementary Information

Supplementary Information Name 001 [15] 002 [15] 004 [15] 006 [15] Subject Characteristics N = 140 (Monovalent HPV-11 Vaccine and Placebo) N = 109 (Monovalent HPV-16 Vaccine and Placebo) N = 480 (Monovalent HPV-16 Vaccine and Placebo)

More information

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com News Release FOR IMMEDIATE RELEASE Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com Merck's HPV Vaccine, GARDASIL 9, now available

More information

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV? What is HPV? HPV Vaccines HPV stands for human papilloma virus. HPVs are a group of more than 150 related viruses. Each HPV virus in the group is given a number, and is called an HPV type (for instance,

More information

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS What is human papillomavirus (HPV)? HPV is the most common sexually transmitted infection. There are

More information

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 12/2015 FULL PRESCRIBING INFORMATION: CONTENTS*

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 12/2015 FULL PRESCRIBING INFORMATION: CONTENTS* HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GARDASIL 9 safely and effectively. See full prescribing information for GARDASIL 9. GARDASIL 9 (Human

More information

Information on: HPV vaccine. jostrust.org.uk

Information on: HPV vaccine. jostrust.org.uk Information on: HPV vaccine jostrust.org.uk HPV vaccine This booklet covers: What is the HPV vaccine? Where can girls get the vaccine? Will being vaccinated prevent all cases of cervical cancer? How effective

More information

Immunizing Pharmacist Signature

Immunizing Pharmacist Signature OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS Yellow Fever 1 01-2016 Vaccination age changed to clients 7 years of age Removal of the Adolescent Well Visit Flyer I. Oregon Immunization

More information

The Kroger Pharmacy Vaccine Administration Training Program Self-Study Quiz

The Kroger Pharmacy Vaccine Administration Training Program Self-Study Quiz The Kroger Pharmacy Vaccine Administration Training Program Self-Study Quiz Name: Date: Score: Please darken the letter on the Answer Sheet (last page) that corresponds to the correct answer, and bring

More information

The Women s Centre Human Papilloma Virus (HPV) Vaccine: Gardasil Information for Patients

The Women s Centre Human Papilloma Virus (HPV) Vaccine: Gardasil Information for Patients The Women s Centre Human Papilloma Virus (HPV) Vaccine: Gardasil Information for Patients What is the Human papilloma Virus (HPV) and why is it Important? Human papilloma virus (HPV) is the name of a family

More information

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET When detected, HPV infection is easily managed and rarely proceeds to cancer Very few women with HPV develop cervical cancer HPV infections are only one of

More information

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV? What is HPV? HPV Vaccines HPV is short for human papilloma virus. HPVs are a group of more than 150 related viruses. Each HPV virus in the group is given a number, which is called an HPV type. HPVs are

More information

HPV Vaccination. Nate Herr MD, Stephanie Lauden MD, James MapelLentz MD, Logan Newman MD, Dawn Martin MD, MPH University of Minnesota Pediatrics

HPV Vaccination. Nate Herr MD, Stephanie Lauden MD, James MapelLentz MD, Logan Newman MD, Dawn Martin MD, MPH University of Minnesota Pediatrics HPV Vaccination Nate Herr MD, Stephanie Lauden MD, James MapelLentz MD, Logan Newman MD, Dawn Martin MD, MPH University of Minnesota Pediatrics Disclosures I have no relevant financial relationships with

More information

Frequently Asked Questions

Frequently Asked Questions PPFA HPV FAQ.qxd /11 2:15 PM Page 1 Frequently Asked Questions PPFA HPV FAQ.qxd /11 2:15 PM Page 2 PPFA HPV FAQ.qxd /11 2:15 PM Page 3 General Questions About HPV PPFA HPV FAQ.qxd /11 2:15 PM Page 4 PPFA

More information

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 04/2015

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 04/2015 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GARDASIL safely and effectively. See full prescribing information for GARDASIL. GARDASIL [Human Papillomavirus

More information

HUMAN PAPILLOMAVIRUS VACCINE Frequently Asked Questions for Health Professionals

HUMAN PAPILLOMAVIRUS VACCINE Frequently Asked Questions for Health Professionals HUMAN PAPILLOMAVIRUS VACCINE Frequently Asked Questions for Health Professionals Produced by the National Immunisation Office in collaboration with the Health Protection Surveillance Centre Version 3 -

More information

Human Papillomavirus Human Papillomavirus Human Papillomavirus Pathogenesis 139

Human Papillomavirus Human Papillomavirus Human Papillomavirus Pathogenesis 139 Human Papillomavirus Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. The relationship of cervical cancer and sexual behavior was suspected for more than

More information

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to:

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to: Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty Upon Completion of the Lesson the student will be able to: Review statistics related to cervical cancer and HPV

More information

Immunization Information for Blinn College Students

Immunization Information for Blinn College Students 1 Immunization Information for Blinn College Students *Important Information Regarding the Bacterial Meningitis Vaccine* The State passed Senate Bill 1107 in 2011 and recently Senate Bill 62 in 2013, which

More information

HPV Vaccine Recommendation Update Webinar

HPV Vaccine Recommendation Update Webinar HPV Vaccine Recommendation Update Webinar Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Friday, April 3, 2015 11:00AM-12:00PM EDT Presenters Lauri

More information

GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883613

GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883613 9883613 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use safely and effectively. See full prescribing information for. [Human Papillomavirus Quadrivalent

More information

Protecting yourself from cervical cancer. The National HPV Vaccination Program.

Protecting yourself from cervical cancer. The National HPV Vaccination Program. Protecting yourself from cervical cancer The National HPV Vaccination Program www.australia.gov.au/cervicalcancer What is cervical cancer? Cervical cancer (cancer of the cervix*) is a disease where abnormal

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale

More information

MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals

MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals What is Bexsero vaccine? Bexsero is a meningococcal Group B (MenB) vaccine which is indicated for the active immunisation of

More information

Questions and Answers about Human Papillomavirus (HPV) Vaccine

Questions and Answers about Human Papillomavirus (HPV) Vaccine Page 1 of 5 Questions and Answers about Human Papillomavirus (HPV) Vaccine A. Information for Providers What is HPV? Human Papillomavirus, (HPV) is one of the most common sexually transmitted infections

More information

Fluzone Vaccine and Influenza Market Update

Fluzone Vaccine and Influenza Market Update Fluzone Vaccine and Influenza Market Update Jay Barber Senior Director, Marketing US Agenda 2013-2014 Fluzone Vaccine Campaign Influenza Immunization: Progress Report Sanofi Pasteur's Commitment to Influenza

More information

Year 7 & 8 Human Papillomavirus (HPV) vaccination

Year 7 & 8 Human Papillomavirus (HPV) vaccination Department of Health Year 7 & 8 Human Papillomavirus (HPV) vaccination PARENT/LEGAL GUARDIAN: to have your child vaccinated, please Read this information and discuss it with your child Complete sections

More information

Importer / Manufacturer: MSD (THAILAND) LTD./ Merck & Co.,Inc., West Point, Pennsylvania 19486 SUMMARY OF PRODUCT CHARACTERISTICS

Importer / Manufacturer: MSD (THAILAND) LTD./ Merck & Co.,Inc., West Point, Pennsylvania 19486 SUMMARY OF PRODUCT CHARACTERISTICS Registration No. 1C 68/47(NC) Importer / Manufacturer: MSD (THAILAND) LTD./ Merck & Co.,Inc., West Point, Pennsylvania 19486 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT VARIVAX [Varicella

More information

The HPV vaccine Beating cervical cancer A Q&A sheet for girls and their parents on the HPV vaccination from September 2014

The HPV vaccine Beating cervical cancer A Q&A sheet for girls and their parents on the HPV vaccination from September 2014 The HPV vaccine Beating cervical cancer A Q&A sheet for girls and their parents on the HPV vaccination from September 2014 Questions and answers This Q&A on HPV vaccine supports the leaflet that your daughter

More information

Influenza Vaccine Protocol Agreement (O.C.G.A. Section 43-34-26.1)

Influenza Vaccine Protocol Agreement (O.C.G.A. Section 43-34-26.1) Influenza Vaccine Protocol Agreement (O.C.G.A. Section 43-34-26.1) This Influenza Vaccine Protocol Agreement (the "Protocol") authorizes the Georgia licensed pharmacists (the "Pharmacists") or nurses (

More information

Vaccine Protocol Agreement. Name of Pharmacy: Address: City, State, Zip:

Vaccine Protocol Agreement. Name of Pharmacy: Address: City, State, Zip: Vaccine Protocol Agreement Name of Pharmacy: Address: City, State, Zip: This Vaccine Protocol Agreement (the "Protocol") authorizes the Georgia licensed pharmacists (the "Pharmacists") or nurses ( Nurses

More information

Varicella and Varicella Vaccine

Varicella and Varicella Vaccine Varicella and Epidemiology and Prevention of Vaccine- Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at http://www.vaccineinformation.org/photos/index.asp

More information

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15

More information

Diseases that can be spread during sex

Diseases that can be spread during sex Diseases that can be spread during sex Did you know... over 65 million people in the United States have a chronic, incurable sexually transmitted disease (STD)? and that every year another 19 million persons

More information

The HPV vaccine Beating cervical cancer questions and answers

The HPV vaccine Beating cervical cancer questions and answers The HPV vaccine A Q&A sheet for girls and their parents on the HPV vaccination available from September 2012 Beating cervical cancer questions and answers Beating cervical cancer questions and answers

More information

Quadrivalent human papillomavirus vaccine (Gardasil)

Quadrivalent human papillomavirus vaccine (Gardasil) Quadrivalent human papillomavirus vaccine (Gardasil) Summary The quadrivalent human papillomavirus (HPV) vaccine protects against infection with HPV types 6, 11, 16 and 18, which are responsible for 70%

More information

Human Papillomavirus (HPV)

Human Papillomavirus (HPV) HPV: Protecting Your Patient from Harm Clinical Advances in Pediatrics Children s Mercy Health Network November 8, 200 Cynthia Holland-Hall, MD, MPH Associate Professor of Clinical Pediatrics The Ohio

More information

MEDICATION GUIDE STELARA

MEDICATION GUIDE STELARA MEDICATION GUIDE STELARA (stel ar a) (ustekinumab) Injection What is the most important information I should know about STELARA? STELARA is a medicine that affects your immune system. STELARA can increase

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Gardasil, suspension for injection in a pre-filled syringe Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed) Read all of this leaflet

More information

HPV IMMUNIZATION GUIDELINES AND TIPS FOR PROVIDERS

HPV IMMUNIZATION GUIDELINES AND TIPS FOR PROVIDERS HPV IMMUNIZATION GUIDELINES AND TIPS FOR PROVIDERS HPV Most types of HPV that infect humans are asymptomatic and transient There are certain oncogenic types that may persist and cause cancers of the cervix,

More information

PCV13 vs PPSV23: Which to Give and When Primary Care Case Conference

PCV13 vs PPSV23: Which to Give and When Primary Care Case Conference PCV13 vs PPSV23: Which to Give and When Primary Care Case Conference Elaine Rosenblatt MSN, FNP BC Internal Medicine Clinic University Station February 27, 2013 Objectives Understand the indications for

More information

HSE National Immunisation Office HUMAN PAPILLOMAVIRUS VACCINE. Frequently Asked Questions for Health Professionals. Version 13.

HSE National Immunisation Office HUMAN PAPILLOMAVIRUS VACCINE. Frequently Asked Questions for Health Professionals. Version 13. HUMAN PAPILLOMAVIRUS VACCINE Frequently Asked Questions for Health Professionals Version 13.0 August 2016 1 HPV Disease and Cervical Cancer What is HPV? Human papillomavirus (HPV) is a virus that infects

More information

ALBERTA IMMUNIZATION POLICY GUIDELINES

ALBERTA IMMUNIZATION POLICY GUIDELINES ALBERTA IMMUNIZATION POLICY GUIDELINES Hepatitis Vaccines. Hepatitis A Vaccines Refer to the vaccine product monograph and the Canadian Immunization Guide for further Product monographs are available on

More information

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013.

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013. The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013 Havrix 720 Junior 1 NAME OF THE MEDICINAL PRODUCT Havrix 720 Junior 2 QUALITATIVE

More information

9/22/2015. Immunization Update Disclosures. Learning Objectives. The speaker has no financial or non-financial disclosures to discuss.

9/22/2015. Immunization Update Disclosures. Learning Objectives. The speaker has no financial or non-financial disclosures to discuss. Immunization Update 2015 Sophia Galloway, Pharm.D. Disclosures The speaker has no financial or non-financial disclosures to discuss. Learning Objectives Upon completion of this program, attendees will

More information

If you have any concerns about being given this vaccine, ask your doctor or pharmacist.

If you have any concerns about being given this vaccine, ask your doctor or pharmacist. PNEUMOVAX 23 Pneumococcal Vaccine Single Dose Vial/Pre-filled Syringe What is in this leaflet This leaflet answers some common questions about PNEUMOVAX 23. It does not contain all the available information.

More information

Vaccination Policy. Background: Meningococcal Disease on Campus

Vaccination Policy. Background: Meningococcal Disease on Campus Vaccination Policy EDMC institutions shall recognize all state and federal vaccination and immunization requirements. Institutions, with the support of EDMC regulatory affairs and compliance and legal

More information

TdaP-Booster (tee-dee-ay-pee boo-ster)

TdaP-Booster (tee-dee-ay-pee boo-ster) New Zealand Consumer Medicine Information TdaP-Booster (tee-dee-ay-pee boo-ster) Tetanus, diphtheria and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content) CONSUMER MEDICINE

More information

Protect Yourself + Protect Your Partner. genital HP. T H e

Protect Yourself + Protect Your Partner. genital HP. T H e Protect Yourself + Protect Your Partner genital HP T H e V Fa ct s Protect Yourself + Protect Your Partner The facts Genital human papillomavirus (/pap pil LO ma VY rus/) (HPV) is the most common sexually

More information

June 8, 2006. Nancy B. Miller, M.D. Medical Officer Vaccines Clinical Trial Branch

June 8, 2006. Nancy B. Miller, M.D. Medical Officer Vaccines Clinical Trial Branch June 8, 2006 From: Nancy B. Miller, M.D. Medical Officer Vaccines Clinical Trial Branch Division of Vaccines and Related Products Applications Office of Vaccines Research and Review Center for Biologics

More information

PRODUCT MONOGRAPH GARDASIL. [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection

PRODUCT MONOGRAPH GARDASIL. [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection PRODUCT MONOGRAPH GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection Active Immunizing Agent Merck Canada Inc. 16750 route Transcanadienne Kirkland,

More information

Is your family at risk for pertussis?

Is your family at risk for pertussis? Is your family at risk for pertussis? Help protect your family against a serious disease and talk to your health-care professional about adult and adolescent immunization with Adacel vaccine. Please click

More information

CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] Suspension for Intramuscular Injection Initial U.S.

CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] Suspension for Intramuscular Injection Initial U.S. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CERVARIX safely and effectively. See full prescribing information for CERVARIX. CERVARIX [Human Papillomavirus

More information

The HPV Vaccine: A Guide for San Francisco Teens

The HPV Vaccine: A Guide for San Francisco Teens The HPV Vaccine: A Guide for San Francisco Teens There s a vaccine available to girls that helps prevent cervical cancer caused by certain types of Human Papillomavirus (HPV). Maybe you ve heard about

More information

NHS FORTH VALLEY. Administration of VZIG in close contact with chicken pox or shingles in a pregnant woman. Unit Clinical Governance

NHS FORTH VALLEY. Administration of VZIG in close contact with chicken pox or shingles in a pregnant woman. Unit Clinical Governance NHS FORTH VALLEY Date of First Issue 01/04/2006 Approved 05/05/2012 Current Issue Date 18/09/2012 Review Date 18/09/2016 Version 1.2 EQIA Yes 01/04/2012 Author / Contact Group Committee Final Approval

More information

Cervical cancer is the second most common cancer among South African women

Cervical cancer is the second most common cancer among South African women Cervical cancer is the second most common cancer among South African women *SA Statistics as per National Cancer Registry (NCR) 2007 What is cervical cancer? Cervical cancer is a type of cancer that occurs

More information

1. Immunization Bulletin 2. Strongest Families BC: a new program for kids with behaviour problems

1. Immunization Bulletin 2. Strongest Families BC: a new program for kids with behaviour problems Physicians Update November 23, 2011 From the Office of the Chief Medical Health Officer 1. Immunization Bulletin 2. Strongest Families BC: a new program for kids with behaviour problems In the immunization

More information

For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only

For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only Easyfive Pentavalent Vaccine For Intramuscular Injection only For Active Immunization against Diphtheria, Tetanus, Whooping

More information

Patient Group Direction PGD No /15 Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil

Patient Group Direction PGD No /15 Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil Notice to all staff: This Patient Group Direction (PGD) may only be used by members of the healthcare professions named on the title page, and only if each professional has individually been listed by

More information

Vaccination to prevent cervical cancer offered to all girls in grade 7 (age 12-13)

Vaccination to prevent cervical cancer offered to all girls in grade 7 (age 12-13) About HPV-vaccination in The Norwegian Childhood Immunisation Programme Information for children and parents in English Vaccination to prevent cervical cancer offered to all girls in grade 7 (age 12-13)

More information

Cover Your Lover: STD Facts

Cover Your Lover: STD Facts The Gable Health Center has partnered with the Pennsylvania State Department of Health to raise STD awareness in the Albright Community through the Cover Your Lover campaign. With approximately 12 million

More information

Human Papilloma Virus (HPV), Cancer, and HPV Vaccines -- Frequently Asked Questions

Human Papilloma Virus (HPV), Cancer, and HPV Vaccines -- Frequently Asked Questions Human Papilloma Virus (HPV), Cancer, and HPV Vaccines -- Frequently Asked Questions What are viruses? Viruses are very small -- most cannot even be seen with a regular microscope -- organisms. They cannot

More information

Influenza Vaccine Frequently Asked Questions. Influenza Control Program

Influenza Vaccine Frequently Asked Questions. Influenza Control Program Influenza Vaccine Frequently Asked Questions Influenza Control Program Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected

More information

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older When to get tested and how to make sense of your test results If you are 30 years or older and your Pap test is normal

More information

What is HPV? Low-risk HPV types. High-risk HPV types

What is HPV? Low-risk HPV types. High-risk HPV types HPV and Cancer What is HPV? HPV is short for human papilloma (PAP-uh-LO-muh) virus. HPVs are a large group of related viruses. Each HPV virus in the group is given a number, which is called an HPV type.

More information

CERVICAL CANCER What every woman should know What is a cervix?

CERVICAL CANCER What every woman should know What is a cervix? CERVICAL CANCER What every woman should know What is a cervix? The cervix is the entrance to the womb from the vagina. It is the narrow, lower part of the uterus that is the passageway connecting the uterus

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT Safety of HPV vaccination: A FIGO STATEMENT July, 2013 Human papillomavirus vaccines are used in many countries; globally, more than 175 million doses have been distributed. Extensive pre- and post-licensure

More information

Let s Learn the Basics about Cervical Cancer

Let s Learn the Basics about Cervical Cancer A Publication of the National Center for Farmworker Health October-December 2014 Let s Learn the Basics about Cervical Cancer What is cancer? The body is made up of millions and millions of living cells.

More information

Hepatitis A Vaccine Biological Page

Hepatitis A Vaccine Biological Page Hepatitis A Vaccine Biological Page Section 7: Biological Product Information Standard #: 07.230 Created by: Province-wide Immunization Program Standards and Quality Approved by: Province-wide Immunization

More information

Facts About Chickenpox and Shingles for Adults

Facts About Chickenpox and Shingles for Adults Facts About Chickenpox and Shingles for Adults What is chickenpox? Chickenpox, also known as varicella, is a very contagious disease caused by the varicella-zoster virus. It is spread easily through the

More information

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Burden of HPV related cancers l l Cervical Cancer of the cervix

More information

Chapter 4: HPV Vaccination. Comprehensive Cervical Cancer Control: A guide to essential practice (C4 GEP)

Chapter 4: HPV Vaccination. Comprehensive Cervical Cancer Control: A guide to essential practice (C4 GEP) Chapter 4: HPV Vaccination Comprehensive Cervical Cancer Control: A guide to essential practice (C4 GEP) February 11, 2013 Contents KEY POINTS... 3 ABOUT THIS CHAPTER... 3 ROLE OF THE HEALTH CARE PROVIDER...

More information

HPV VACCINE Evidence-Based HPV Prevention

HPV VACCINE Evidence-Based HPV Prevention HPV VACCINE Evidence-Based HPV Prevention Katy Sheridan, MD Winter Update Alaska AFP Girdwood, Alaska March 13, 2015 2:00pm Objectives 1. Define the importance of HPV vaccination for cancer prevention

More information

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule TO PROMOTE AND PROTECT THE HEALTH

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Gardasil, suspension for injection. Gardasil, suspension for injection in a pre-filled syringe. Human Papillomavirus Vaccine

More information

Hubka and Wisner Vaccinations Recommended During Pregnancy and Breastfeeding

Hubka and Wisner Vaccinations Recommended During Pregnancy and Breastfeeding Optimal protection against preventable diseases for the pregnant woman and her fetus can be provided through vaccination prior to pregnancy. When indicated, however, the benefits of immunization during

More information

Wednesday, April 24, 13 MEN S HEALTH

Wednesday, April 24, 13 MEN S HEALTH MEN S HEALTH STDS and OTHER INFECTIOUS DISEASES STDS 15 million americans get STDs every year. STDs are easily preventable - but people aren t doing it? Why? Monogamous sex with uninfected partner Use

More information

HPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION

HPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION What is HPV? 1 Frequently Asked Questions HPVs, or human papillomaviruses, are common viruses that cause warts and cancers and the most common viral sexually transmitted infection (STI). There are over

More information

Consultation Group: See relevant page in the PGD. Review Date: July 2016

Consultation Group: See relevant page in the PGD. Review Date: July 2016 Patient Group Direction For The Administration Of Gardasil Vaccine Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, Adsorbed) By Nurses, Midwives and Health Visitors Working Within NHS

More information

Pneumococcal Polysaccharide Immunization Clinical Guidelines 2014/2015

Pneumococcal Polysaccharide Immunization Clinical Guidelines 2014/2015 Pneumococcal Polysaccharide Immunization Clinical Guidelines 2014/2015 Pneumococcal polysaccharide vaccine is used to prevent serious illness caused by the Streptococcus pneumoniae bacteria. The immunization

More information

2009 Novel H1N1 Influenza Vaccine Key Points

2009 Novel H1N1 Influenza Vaccine Key Points General Information 2009 Novel H1N1 Influenza Vaccine Key Points Messages: Please be patient. Vaccine will be coming. Meanwhile, use other prevention methods such as hand washing, covering coughs and sneezes,

More information

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine and clarification of minimum

More information

Human Papillomavirus (HPV) and Cervical Cancer Fact Sheet. Almost all cervical cancers more than 99 percent are caused by HPV. 2

Human Papillomavirus (HPV) and Cervical Cancer Fact Sheet. Almost all cervical cancers more than 99 percent are caused by HPV. 2 Fast Facts Human Papillomavirus (HPV) and Cervical Cancer Fact Sheet Human papillomavirus (HPV) is a common infection transmitted during sexual contact and those affected often do not show symptoms. 1

More information

Pap Tests, HPV Screening, and the HPV Vaccine

Pap Tests, HPV Screening, and the HPV Vaccine Pap Tests, HPV Screening, and the HPV Vaccine George F. Sawaya, MD Associate Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University

More information

TWINRIX (720/20) and TWINRIX JUNIOR (360/10) Combined hepatitis A and hepatitis B vaccine

TWINRIX (720/20) and TWINRIX JUNIOR (360/10) Combined hepatitis A and hepatitis B vaccine TWINRIX (720/20) and TWINRIX JUNIOR (360/10) Combined hepatitis A and hepatitis B vaccine CONSUMER MEDICINE INFORMATION LEAFLET In this leaflet, TWINRIX refers to both TWINRIX (720/20) and TWINRIX JUNIOR

More information

Prophylaxis Against Human Papillomavirus Infections with Gardasil Vaccine by Jaime Anderson, Pharm.D.

Prophylaxis Against Human Papillomavirus Infections with Gardasil Vaccine by Jaime Anderson, Pharm.D. Mandy C. Leonard, Pharm.D., BCPS Assistant Director, Drug Information Service Editor Meghan K. Lehmann, Pharm.D., BCPS Drug Information Specialist Editor Dana L. Travis, R.Ph. Drug Information Pharmacist

More information

Sex, Lies, and Vaccination: HPV - the big facts

Sex, Lies, and Vaccination: HPV - the big facts Sex, Lies, and Vaccination: HPV - the big facts FRANCOISE BAYLIS Canada Research Chair Bioethics and Philosophy February 2009 Halifax, Canada Human Papillomavirus (HPV) HPV is the most common sexually

More information

HPV disease. Andrea Milbourne, MD Department of Gynecologic Oncology and Reproductive Medicine UT MD Anderson Cancer Center

HPV disease. Andrea Milbourne, MD Department of Gynecologic Oncology and Reproductive Medicine UT MD Anderson Cancer Center HPV disease Andrea Milbourne, MD Department of Gynecologic Oncology and Reproductive Medicine UT MD Anderson Cancer Center Objectives Understand the burden of HPV caused disease in the US and Texas Review

More information

A P P E N D I X SAMPLE FORMS

A P P E N D I X SAMPLE FORMS A P P E N D I X A SAMPLE FORMS Authorization for Disclosure Consent for HBV/HCV Antigens, HIV Antibody Documentation of Staff Education Employees Eligible for Hepatitis-B Vaccination Hepatitis-A Consent

More information

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009 Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians December 14, 2009 Table of Contents Preface... iii Significant Changes in the Vaccination Requirements... 1 Procedure

More information

WPC-V501-I GARDASIL. [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine]

WPC-V501-I GARDASIL. [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine] WPC-V501-I-022011 1 GARDASIL NEW ZEALAND DATA SHEET [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine] DESCRIPTION GARDASIL is a recombinant, quadrivalent vaccine. The quadrivalent

More information

Fluzone Vaccine and Influenza Market Update

Fluzone Vaccine and Influenza Market Update Fluzone Vaccine and Influenza Market Update Phil Hosbach, Vice President Immunization Policy Agenda 2012-2013 Fluzone Vaccine Campaign Influenza Immunization: Progress report Sanofi Pasteur's Commitment

More information

Vaccinations and Spina Bifida and Hydrocephalus

Vaccinations and Spina Bifida and Hydrocephalus shinecharity.org.uk info@shinecharity.org.uk 42 Park Road Peterborough PE1 2UQ 01733 555988 Vaccinations and Spina Bifida and Hydrocephalus Vaccines are made from parts of bacteria or viruses that cause

More information

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH)

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) What is pertussis? General Questions About Pertussis Pertussis, or whooping cough, is a contagious illness that is spread when an infected person

More information